Free tool
Diagnostics stocks
We cover 10 companies grouped under the Diagnostics theme. The median market value in the group is $413.78M. Across the group, the median move over the past trading day is +0.15%. Price change over the past year runs from −24.5% to +41.3% across the middle 80 percent of the group, with a median of −9.5%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
10 of 150 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| 0KSX.L | Quest Diagnostics Incorporated | $27.60B | Large cap | +36.94% | Oct 20, 2026 |
| QIA.DE | Qiagen N.V. | $8.85B | Mid cap | −11.42% | Nov 4, 2026 |
| ALIF-B.ST | AddLife AB (publ) | $2.09B | Mid cap | −7.56% | Oct 21, 2026 |
| DIA.WA | Diagnostyka S.A. | $1.54B | Small cap | −17.53% | Sep 10, 2026 |
| CEVI.ST | CellaVision AB (publ) | $413.78M | Small cap | −3.32% | Oct 28, 2026 |
| NIOX.L | NIOX Group Plc | $382.51M | Small cap | −6.05% | Sep 29, 2026 |
| 0KCC.L | Insight Molecular Diagnostics Inc. | $339.65M | Small cap | +80.26% | Nov 9, 2026 |
| SBS.DE | Stratec SE | $324.34M | Small cap | −16.29% | Nov 12, 2026 |
| 0RAR.L | Stratec SE | $275.63M | Small cap | −13.37% | Nov 12, 2026 |
| 0A50.L | Co-Diagnostics, Inc. | — | — | −87.23% | Nov 16, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.